Healthtech, care management, VBC, payer-facing, and provider enablement teams
Payer Strategy and Value-Based Care

Payer and value-based-care GTM support across reimbursement logic, VBC economics, managed care narratives, care-gap proof, and buyer-ready value realization.
Read the operating briefFrom payer pain to a defensible funding case
- Name the urgent payer problem
Frame cost, quality, access, care gaps, and operational feasibility.
- Separate proof from assumptions
Build a value-realization model with explicit opportunity ranges.
- Prioritize launchable accounts
Compare buyer pain, economics, partner fit, and implementation burden.
- Support the funding decision
Present reimbursement logic, proof gates, and executive-ready value materials.
The buyer problem
The issue underneath the visible activity.
This is the problem leadership must make legible before adding more pipeline, tooling, headcount, or implementation burden.
The product may create value, but the buyer does not yet see the economics, reimbursement path, proof gates, or implementation model clearly enough to act.
What gets built
A working management system, not a recommendation left in a deck.
The scope is organized around the artifacts, operating rules, and decision cadence the team needs to keep using after the engagement.
- 01
Payer-facing narrative around cost, quality, access, care gaps, and operational feasibility.
- 02
Value-realization model that separates verified proof from assumptions and opportunity ranges.
- 03
Account and partner prioritization based on buyer pain, economics, and launchability.
- 04
Executive materials that help CEOs and CFOs decide what to fund next.
Proof patterns
What leadership should be able to observe.
- 01
VBC contract logic across payer/provider contexts.
- 02
HEDIS/Stars, RAF/HCC, CMS-HCC V28, Managed Medicaid, Medicare Advantage, CKCC/KCC, and care-gap economics fluency.
- 03
Claims-informed opportunity mapping converted into provider and service-line decisions.
Decision questions
What the executive room must answer.
- 01
Which payer pain is urgent enough to create action?
- 02
What value proof will survive CFO scrutiny?
- 03
What implementation burden could block the sale after agreement?
Trust boundary
What this mandate will not pretend away.
- Do not pitch value-based care without a measurable proof path.
- Do not blend Medicare ACO economics with Medicaid or HRSN value without labeling the lens.
- Do not assume every mission-aligned partner is financially launchable.
Connected context
Follow the system beyond this mandate.
Start a serious conversation